Author

Li-Guo Wang

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Tectorigenin ameliorates HFpEF through the EGFR-EGR2-Acot1 axis, highlighting a potential therapeutic strategy for HFpEF.

Li-Guo Wang, Ke Lin, Meng-Zhen You et al. · Acta Pharmacologica Sinica · 0 citations